Study of worsening lung symptoms in people with IPF
Part of Lungs & breathing clinical trials.
This study looks at people with idiopathic pulmonary fibrosis (IPF) who are currently having a sudden worsening of breathing symptoms. It may help doctors better understand what happens during these flare-ups and how to manage them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted to the hospital because your breathing symptoms have increased suddenly
- You must already be enrolled in the study’s related IPF research group (PFBIO) or enroll at the same time as both related groups (PFBIO and PFBIO-EXA)
- Be able to understand the study and agree to take part (able to give informed consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether routine blood test results can help doctors understand and manage sudden flare-ups of idiopathic pulmonary fibrosis (IPF), a lung disease. If you are admitted to the hospital with a sudden worsening, your blood tests may provide important clues.
This study looks at how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated, and how it affects patients' daily lives. It aims to learn from both patients and their doctors to improve care.
This study is looking at people with Idiopathic Pulmonary Fibrosis (IPF), a type of lung scarring. Researchers will use medical records to see if they can better predict how the disease will progress over time.
This trial tests whether giving a medication called intravenous immunoglobulin (IVIG) can help people with IPF who are hospitalized for a sudden worsening of their lung condition. The treatment aims to reduce inflammation and improve recovery.
This study looks at how well people with IPF can exercise and how strong their breathing muscles are. It helps doctors understand the effects of IPF on daily activity.
This study monitors your vital signs before and after a sudden worsening (flare-up) of IPF. It uses a wearable device (Bora Band®) to track your health and help doctors better understand and manage these events.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.